Literature DB >> 19433741

Hyposmia in pure autonomic failure.

L Silveira-Moriyama1, C Mathias, L Mason, C Best, N P Quinn, A J Lees.   

Abstract

BACKGROUND: Parkinson disease (PD), multiple system atrophy (MSA), and pure autonomic failure (PAF) all present with varying degrees of dysautonomia and are pathologically characterized by accumulation of alpha-synuclein. Hyposmia and olfactory pathway pathology are found in PD and MSA. We tested odor identification in 16 patients with PAF and compared the results with those found in patients with PD, patients with MSA, and control subjects.
METHODS: The University of Pennsylvania Smell Identification Test (UPSIT) was used to evaluate the sense of smell in 16 patients with PAF, 14 patients with MSA, 191 patients with PD, and 145 control subjects. Multiple linear regression analyses were used to evaluate the effect of the diseases on the mean UPSIT score when adjusted for age, sex, and smoking habit.
RESULTS: The mean UPSIT score was higher in the controls than in patients with PAF (p < 0.001) or MSA (p < 0.001); it was lower in patients with PD than in patients with PAF (p = 0.005) or patients with MSA (p = 0.006); and no difference was found between patients with MSA and patients with PAF (p = 0.9) when adjusted for age, gender, and smoking habits.
CONCLUSIONS: Hyposmia may be a feature of pure autonomic failure (PAF), but to a lesser degree than that found in Parkinson disease. Further research into the olfactory pathways in patients with PAF is warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19433741     DOI: 10.1212/WNL.0b013e3181a55fd2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  A cross-sectional study contrasting olfactory function in autonomic disorders.

Authors:  E M Garland; S R Raj; A C Peltier; D Robertson; I Biaggioni
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

Review 2.  Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

Authors:  Michelle E Fullard; James F Morley; John E Duda
Journal:  Neurosci Bull       Date:  2017-08-22       Impact factor: 5.203

Review 3.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

Review 4.  Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Authors:  David S Goldstein; Risa Isonaka; Guillaume Lamotte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2021-10-20       Impact factor: 4.435

Review 5.  Pure Autonomic Failure.

Authors:  Pariwat Thaisetthawatkul
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

6.  Idiopathic REM Sleep Behavior Disorder: Implications for the Pathogenesis of Lewy Body Diseases.

Authors:  Tomoyuki Miyamoto; Masayuki Miyamoto; Masaoki Iwanami; Koichi Hirata
Journal:  Parkinsons Dis       Date:  2011-04-17

7.  The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.

Authors:  Masahiko Suzuki; Masaya Hashimoto; Masayuki Yoshioka; Maiko Murakami; Keiichi Kawasaki; Mitsuyoshi Urashima
Journal:  BMC Neurol       Date:  2011-12-22       Impact factor: 2.474

8.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

9.  Very late-onset pure autonomic failure.

Authors:  Alessandra Fanciulli; Nadia Stefanova; Christoph Scherfler; Patrizia Moser; Klaus Seppi; Elke R Gizewski; Irene Virgolini; Sylvia Boesch; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2017-04-24       Impact factor: 10.338

Review 10.  Current Management and Emerging Therapies in Multiple System Atrophy.

Authors:  Matthew R Burns; Nikolaus R McFarland
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.